Since 2001, additional studies with BAC and leukemic blood have been conducted by independent researchers from a Quebec Hospital Medical University. The preliminary clinical results of in vitro tests consistently showed that BAC was able to normalize leukemic blood as seen converging towards the dotted line on this image. Interestingly, these same tests demonstrated that BAC was more efficient when administered in smaller dose (0.14mg vs 1.4mg) frequently rather than in larger doses applied infrequently.
